Evercore
EVR NYSE Investment Banking & Brokerage Financials FY2016βFY2025
Evercore's revenue rose 29.5% to $3.9 billion in fiscal 2025. Its net margin was 15.3%, up from 12.6% a year earlier. Free cash flow was $1.2 billion, up 23.4%. It paid out $144 million in dividends and buybacks, 12% of free cash flow. The diluted share count rose 1.2%.
What Evercore does
No business description yet.
- Legal name
- EVERCORE INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-010273
0001360901
Revenue and margins
Evercore had $3.9B of revenue in fiscal 2025, up 29.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 21.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 30.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Evercore returned $144M to shareholders in fiscal 2025, 12% of free cash flow. The diluted share count rose 1.2%.
Value Evercore yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $2.4B and divides by 42.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 14.2x Β· peers 25.4x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Evercore can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.4B | $2.1B | $2.0B | $2.4B | $3.0B |
| Debt incl. finance leases | $376M | $372M | $374M | $374M | $588M |
| Net debt / EBITDA | β1.7x | β2.3x | β4.1x | β3.5x | β2.9x |
| Debt / equity | 0.3x | 0.2x | 0.2x | 0.2x | 0.3x |
| Interest coverage | 64.5x | 42.8x | 22.9x | 32.8x | 33.7x |
| Current ratio | 2.2x | 2.5x | 2.9x | 2.4x | 2.2x |
| Quick ratio | 2.2x | 2.5x | 2.9x | 2.4x | 2.2x |
| Total assets | $3.8B | $3.6B | $3.7B | $4.2B | $5.4B |
| Total liabilities | $2.2B | $1.9B | $1.9B | $2.2B | $3.0B |
| Shareholders' equity | $1.3B | $1.5B | $1.6B | $1.7B | $2.0B |
| Net debt (β = net cash) | β$2.0B | β$1.7B | β$1.7B | β$2.0B | β$2.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
1 insider
Sold, 12 months
$5.1M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Timothy Gilbert LaLondeChief Financial Officer | Sold | 7,808 | $343.06 | $2.7M | Form 4 |
| Mar 6, 2026 | Sarah K WilliamsonDirector | Bought | 2,000 | $290.43 | $0.6M | Form 4 |
| Feb 6, 2026 | Jason KlurfeldGeneral Counsel | Sold | 5,000 | $360.00 | $1.8M | Form 4 |
| Feb 5, 2026 | Paul PensaContr, Prin. Acct.Officer | Sold | 1,450 | $350.31 | $0.5M | Form 4 |
| Dec 9, 2025 | Pamela G CarltonDirector | Sold | 192 | $343.11 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β5.5% | β15.5% | β13.9% |
| Altman Z'' | 6.34 | 6.23 | 5.94 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Evercore EVR | $10.4B | 29.5% | β | 30.5% | β | 14.2x | 5 | |
| Virtu Financial VIRT | $4.9B | 26.3% | β | 13.6% | 37.9% | 9.3x | β | Compare β |
| Robinhood HOOD | $86.7B | 51.6% | β | 36.3% | β | 41.9x | β | Compare β |
| BGC Group BGC | $5.6B | 30.0% | β | 12.7% | 13.2% | 28.8x | β | Compare β |
| Houlihan Lokey HLI | $8.9B | 9.6% | 20.1% | 26.1% | β | 22.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.5B | $1.7B | $2.1B | $2.0B | $2.3B | $3.3B | $2.8B | $2.4B | $3.0B | $3.9B |
| Interest expense | $16.7M | $20.0M | $17.8M | $20.1M | $21.4M | $17.6M | $16.8M | $16.7M | $16.8M | $24.3M |
| Pretax income | $268M | $438M | $551M | $449M | $541M | $1.1B | $704M | $366M | $533M | $794M |
| Income tax | $119M | $258M | $109M | $95.0M | $128M | $248M | $173M | $80.6M | $115M | $153M |
| Net income | $108M | $126M | $377M | $297M | $351M | $740M | $477M | $256M | $378M | $592M |
| Diluted EPS | $2.43 | $2.80 | $8.33 | $6.89 | $8.22 | $17.08 | $11.61 | $6.37 | $9.08 | $14.05 |
| Diluted shares | 0.04B | 0.04B | 0.05B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $422M | $507M | $850M | $505M | $978M | $1.4B | $531M | $458M | $988M | $1.3B |
| Capital expenditure | $18.4M | $31.3M | $33.3M | $70.8M | $53.3M | $28.0M | $23.2M | $20.0M | $30.1M | $74.0M |
| Free cash flow | $403M | $476M | $816M | $434M | $925M | $1.4B | $508M | $438M | $958M | $1.2B |
| Depreciation and amortization | $13.2M | $15.0M | $17.9M | $22.9M | $24.6M | $27.7M | $27.4M | $24.3M | $24.5M | $28.9M |
| Stock-based compensation | $258M | $230M | $294M | $360M | $367M | $422M | $467M | $515M | $570M | $675M |
| Acquisitions | $2.9M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $51.6M | $56.5M | $77.3M | $96.8M | $107M | $119M | $127M | $128M | $136M | $144M |
| Dividends and buybacks | $51.6M | $56.5M | $77.3M | $96.8M | $107M | $119M | $127M | $128M | $136M | $144M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $625M | $738M | $1.1B | $1.3B | $1.9B | $2.4B | $2.1B | $2.0B | $2.4B | $3.0B |
| Total debt | β | β | β | $375M | $377M | $376M | $372M | $374M | $374M | $588M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $926M | $1.0B | $1.5B | $1.7B | $2.4B | $2.8B | $2.7B | $2.6B | $3.0B | $3.9B |
| Current liabilities | $463M | $464M | $750M | $669M | $1.1B | $1.3B | $1.1B | $910M | $1.2B | $1.8B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $51.7M | $68.6M | $81.1M | $127M | $149M | $149M | $143M | $138M | $145M | $190M |
| Total assets | $1.7B | $1.6B | $2.1B | $2.6B | $3.4B | $3.8B | $3.6B | $3.7B | $4.2B | $5.4B |
| Total liabilities | $879M | $789M | $1.1B | $1.5B | $1.9B | $2.2B | $1.9B | $1.9B | $2.2B | $3.0B |
| Shareholders' equity | $527M | $544M | $758M | $870M | $1.2B | $1.3B | $1.5B | $1.6B | $1.7B | $2.0B |
| Margins | ||||||||||
| EBITDA margin | 20.4% | 27.4% | 28.2% | 24.2% | 25.7% | 35.1% | 26.9% | 16.7% | 19.2% | 21.8% |
| Net margin | 7.4% | 7.3% | 18.1% | 14.7% | 15.3% | 22.4% | 17.2% | 10.5% | 12.6% | 15.3% |
| FCF margin | 27.7% | 27.6% | 39.2% | 21.4% | 40.5% | 41.0% | 18.3% | 17.9% | 32.0% | 30.5% |
| Returns | ||||||||||
| Return on capital employed | 25.1% | 39.5% | 45.6% | 28.4% | 26.5% | 47.1% | 28.5% | 14.3% | 19.2% | 25.1% |
| Return on equity | 20.8% | 23.4% | 57.9% | 36.5% | 33.4% | 58.0% | 33.4% | 16.4% | 23.0% | 31.7% |
| Return on assets | 6.9% | 7.7% | 20.3% | 12.6% | 11.8% | 20.6% | 12.8% | 7.0% | 9.6% | 12.4% |
| Growth | ||||||||||
| Revenue growth | 17.5% | 18.4% | 20.8% | β2.6% | 12.6% | 44.7% | β16.0% | β12.1% | 22.7% | 29.5% |
| Net income growth | 150.9% | 16.7% | 200.7% | β21.2% | 17.9% | 111.1% | β35.6% | β46.4% | 48.1% | 56.5% |
| EPS growth | 148.0% | 15.2% | 197.5% | β17.3% | 19.3% | 107.8% | β32.0% | β45.1% | 42.5% | 54.7% |
| FCF growth | 14.8% | 18.0% | 71.5% | β46.8% | 113.2% | 46.7% | β62.6% | β13.8% | 118.8% | 23.4% |
| Share count change | 1.1% | 1.4% | 1.0% | β4.6% | β1.3% | 1.6% | β5.3% | β2.3% | 3.9% | 1.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β1.8x | β2.6x | β1.7x | β2.3x | β4.1x | β3.5x | β2.9x |
| Debt / equity | β | β | β | 0.4x | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x | 0.3x |
| Interest coverage | 17.0x | 22.9x | 32.0x | 23.3x | 26.3x | 64.5x | 42.8x | 22.9x | 32.8x | 33.7x |
| Current ratio | 2.0x | 2.2x | 2.0x | 2.5x | 2.2x | 2.2x | 2.5x | 2.9x | 2.4x | 2.2x |
| Quick ratio | 2.0x | 2.2x | 2.0x | 2.5x | 2.2x | 2.2x | 2.5x | 2.9x | 2.4x | 2.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.3% | 1.8% | 1.6% | 3.5% | 2.3% | 0.9% | 0.8% | 0.8% | 1.0% | 1.9% |
| Stock comp / revenue | 17.7% | 13.4% | 14.1% | 17.8% | 16.1% | 12.8% | 16.8% | 21.1% | 19.0% | 17.4% |
| Payouts / FCF | 12.8% | 11.9% | 9.5% | 22.3% | 11.5% | 8.8% | 25.0% | 29.2% | 14.2% | 12.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | 5.0 | 6.0 | 6.0 | 5.0 | 6.0 | 5.0 |
| Altman Z'' | 4.0 | 5.4 | 5.6 | 5.3 | 5.3 | 6.6 | 6.9 | 6.3 | 6.2 | 5.9 |
| Accruals ratio | β20.0% | β23.5% | β25.5% | β8.8% | β21.0% | β18.0% | β1.5% | β5.5% | β15.5% | β13.9% |
Source: SEC EDGAR XBRL filings (CIK 0001360901). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.